# Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®

> **NCT06375343** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 32 (estimated)

## Conditions studied

- Dry Eye Disease
- Dry Eye Sensation
- Ocular Surface Disease

## Interventions

- **DRUG:** PRO-240
- **DRUG:** Optive®

## Key facts

- **NCT ID:** NCT06375343
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-30
- **Primary completion:** 2027-01-30
- **Final completion:** 2027-01-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06375343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06375343, "Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06375343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*